Show simple item record

dc.contributor.authorAldrugh, Summer
dc.contributor.authorSardana, Mayank
dc.contributor.authorLessard, Darleen M.
dc.contributor.authorSaczynski, Jane S.
dc.contributor.authorMcManus, David D.
dc.date2022-08-11T08:08:16.000
dc.date.accessioned2022-08-23T15:48:33Z
dc.date.available2022-08-23T15:48:33Z
dc.date.issued2017-05-16
dc.date.submitted2017-06-25
dc.identifier.doi10.13028/cf5b-wd26
dc.identifier.urihttp://hdl.handle.net/20.500.14038/28235
dc.description.abstractBackground: Atrial fibrillation (AF) is associated with cognitive and psychosocial comorbidities, and poorer quality of life (QOL). In this study, we aimed to study the association between cognition, psychosocial status and QOL at baseline and AF recurrence. Methods: We enrolled 222 symptomatic AF patients (64±10.0 years, 36% women) treated with a rhythm-control strategy. We performed cognitive, psychosocial, and QOL assessments using Montreal cognitive assessment (MOCA, cognitive impairment Results: A total of 123 (55%) participants experienced an AF recurrence over the 6-month follow-up period. Participants with an AF recurrence had higher rates of depression (31% vs.14%, p=0.022) and lower QOL (62±24 vs. 72±21, p=0.003) at baseline than did participants free from recurrence. In multivariable logistic regression models, lower baseline QOL, but not depression, anxiety, or cognition, was associated with a significantly higher odds of AF recurrence event (Odds Ratio: 0.98, CI 0.97-0.99). Conclusion: Lower AF-related QOL is associated with higher odds of AF recurrence over 6 months among symptomatic AF patients treated with rhythm control. Patient-reported variables have not previously been considered as risk factors for disease progression or prognosis. Our data suggests QOL may serve as a useful tool to aid clinicians in the management of AF patients.
dc.formatflash_audio
dc.language.isoen_US
dc.rightsCopyright the Author(s)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/
dc.subjectatrial fibrillation
dc.subjectquality of life
dc.subjectpsychosocial factors
dc.subjectcognition
dc.subjectCardiology
dc.subjectCardiovascular Diseases
dc.subjectEpidemiology
dc.subjectMental and Social Health
dc.subjectTranslational Medical Research
dc.titleAssociation between Psychosocial Factors, Quality of Life and Atrial Fibrillation
dc.typePoster Abstract
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1483&context=cts_retreat&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cts_retreat/2017/posters/8
dc.identifier.contextkey10348553
refterms.dateFOA2022-08-23T15:48:33Z
html.description.abstract<p><strong>Background: </strong>Atrial fibrillation (AF) is associated with cognitive and psychosocial comorbidities, and poorer quality of life (QOL). In this study, we aimed to study the association between cognition, psychosocial status and QOL at baseline and AF recurrence.</p> <p><strong>Methods: </strong>We enrolled 222 symptomatic AF patients (64±10.0 years, 36% women) treated with a rhythm-control strategy. We performed cognitive, psychosocial, and QOL assessments using Montreal cognitive assessment (MOCA, cognitive impairment</p> <p><strong>Results: </strong>A total of 123 (55%) participants experienced an AF recurrence over the 6-month follow-up period. Participants with an AF recurrence had higher rates of depression (31% vs.14%, <em>p=</em>0.022) and lower QOL (62±24 vs. 72±21, <em>p=</em>0.003) at baseline than did participants free from recurrence. In multivariable logistic regression models, lower baseline QOL, but not depression, anxiety, or cognition, was associated with a significantly higher odds of AF recurrence event (Odds Ratio: 0.98, CI 0.97-0.99).</p> <p><strong>Conclusion: </strong>Lower AF-related QOL is associated with higher odds of AF recurrence over 6 months among symptomatic AF patients treated with rhythm control. Patient-reported variables have not previously been considered as risk factors for disease progression or prognosis. Our data suggests QOL may serve as a useful tool to aid clinicians in the management of AF patients.</p>
dc.identifier.submissionpathcts_retreat/2017/posters/8


Files in this item

Thumbnail
Name:
7_Aldrugh_3.docx
Size:
21.91Kb
Format:
Microsoft Word 2007
Thumbnail
Name:
auto_convert.pdf
Size:
115.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright the Author(s)
Except where otherwise noted, this item's license is described as Copyright the Author(s)